Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).
about
Allergen injection immunotherapy for seasonal allergic rhinitisAsthma: clinical expression and molecular mechanismsThe role of allergen exposure and avoidance in asthmaIncidence of asthma and mortality in a cohort of young adults: a 7-year prospective study.Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study.Allergen-specific immunotherapy in pediatric allergic asthmaUnited airway disease: current perspectivesSublingual Immunotherapy: A Useful Tool for the Allergist in Private PracticeCritical appraisal of Timothy grass pollen extract GRAZAX in the management of allergic rhinitis.A systematic review of predictive models for asthma development in childrenAllergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific ImmunotherapySafety of engineered allergen-specific immunotherapy vaccinesRole of immunotherapy in the treatment of allergic asthmaInduction of tolerance via the sublingual route: mechanisms and applicationsAllergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageinImmunological mechanisms of allergen-specific immunotherapyIdentification of critical amino acids in an immunodominant IgE epitope of Pen c 13, a major allergen from Penicillium citrinumUpdate on allergy immunotherapyAllergic rhinitis: evidence for impact on asthmaAllergic rhinitis and asthma: inflammation in a one-airway condition.Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax(®)) in childrenThe National Institutes of Allergy and Infectious Diseases networks on asthma in inner-city children: an approach to improved careIntermittent allergic rhinitis.Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.Clinical utility and patient adherence with ebastine for allergic rhinitis.Clinical practice guideline: Allergic rhinitis.Immune mechanisms of allergen-specific sublingual immunotherapy.Regulatory T cells in many flavors control asthma'EUROPART'. Airborne particles in the indoor environment. A European interdisciplinary review of scientific evidence on associations between exposure to particles in buildings and health effects.Effects of nasal corticosteroids on boosts of systemic allergen-specific IgE production induced by nasal allergen exposureImmunotherapy reduces allergen-mediated CD66b expression and myeloperoxidase levels on human neutrophils from allergic patients.Intralymphatic immunotherapyLinks between rhinitis and asthma.Improving the management of atopic disease.Joint incidence of asthma and rhinitis in macedonia.Actual therapeutic management of allergic and hyperreactive nasal disordersEarly detection of allergic diseases in otorhinolaryngologyMolecular evolution of hypoallergenic hybrid proteins for vaccination against grass pollen allergy.Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.
P2860
Q24243115-6183CD47-2D66-4498-8E2F-10D11CBC370AQ24597331-482A810E-1FED-4131-A035-532F6A2DE252Q24612008-941EB439-E807-42D2-B4B7-40668F1A3A42Q24812520-6AC92CC2-CCED-4F40-94D3-30CB9D173A35Q25255771-25250587-4E72-4379-9B0B-328D8C33DF43Q26739254-7ACC3689-F652-47BF-BA07-EE0C2A3B5166Q26743436-E6921981-966C-4ACB-8D07-1989B9CDF968Q26747200-2CF45CF4-220B-4400-9A1A-DA57790849D0Q26775905-CD52D94C-2A31-4A8B-89B0-577DFA1F400FQ26776289-EBA643F9-D9F1-4632-AF0F-E3B27F6254DEQ26852113-5B04FE42-A013-4BBD-8237-14F52276A5E6Q26860962-E045AD6E-1011-47ED-9FBA-10B8F489DAC4Q27021489-29DF54CB-7EC1-4F2D-86C8-FE27F0D88F72Q27022140-0C113935-7429-4FFB-B180-8E089154AF4DQ28077951-E3D41BC9-C022-4138-94F3-57C2BE453AE7Q28265326-4D337ABB-A371-4DE3-98F2-0E7B2BF27DB0Q28482224-7BDB727C-8166-4EE3-9CD9-4B3E969327DCQ30436062-0C03C79C-88D6-4EAB-9920-76C3F26A8269Q33265228-CB3EB98B-466A-472B-979D-15B982DFF593Q33265229-E33F55DA-7C89-4D59-8A79-FF836667DBF4Q33573199-2D890AA0-9F86-45D3-A07F-158C2DC7DAD9Q33789484-D7AC4D53-BFAA-43F7-89FE-8C474E0787D0Q33900797-BFFCADE1-0632-4598-A4B5-9D2C8D2F41AEQ34005065-65CA10F4-C28E-4DD2-A10E-FCFFE30CDBF4Q34106036-55A408D1-047D-4EEB-8AF9-93F38425E506Q34413618-5B60A840-4D58-4A45-93FE-EEF920E18196Q34460983-F769C19A-5614-4128-8359-60FE23A24A4FQ34484071-35D12908-8604-4740-8236-071B9ACC540DQ34574231-EA192992-F6B2-43F7-A48C-85F6439190E7Q35074339-EA79D149-FA77-4FC1-BA46-082A0C558F73Q35113146-80198692-4DC0-4A4D-BAD2-0CB3B65E6A76Q35150494-668503CF-ABDE-42C1-BDCC-8989EE2EDCF8Q35155423-17740FE1-1A76-4E1A-B0FF-1D303A808341Q35177431-FAEF4E46-8446-4A2D-B86E-0F68D52CFE21Q35284399-B6785503-D541-4EB2-9723-626CC80D8930Q35426565-BDD924D3-0E26-473C-8270-DBE62671BC21Q35427205-97CAC524-726A-4FC8-83C4-9EE27A41E5E5Q35427549-52728FC2-034E-4FF1-B007-84C1DD718E37Q35558343-3C3BE796-C5E0-45AB-A1B6-A7F82F966CA5Q35566610-7EA5246D-57B6-4745-8237-67A1D117A17B
P2860
Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Pollen immunotherapy reduces t ...... onjunctivitis (the PAT-study).
@en
type
label
Pollen immunotherapy reduces t ...... onjunctivitis (the PAT-study).
@en
prefLabel
Pollen immunotherapy reduces t ...... onjunctivitis (the PAT-study).
@en
P2093
P921
P356
P1476
Pollen immunotherapy reduces t ...... onjunctivitis (the PAT-study).
@en
P2093
Antti Koivikko
Bodo Niggemann
Christian Möller
Dieter Y Koller
Erkka Valovirta
Hosne A Ferdousi
Lars Jacobsen
Lene A Norberg
Radvan Urbanek
P304
P356
10.1067/MAI.2002.121317
P407
P577
2002-02-01T00:00:00Z